Andrea B.
- Country
- Italy
- Department
- U.O.C. Clinica Pneumologica
Research Overview
- A Phase 2b Dose-Ranging Study of Oral KT-621 in Adults with Uncontrolled Moderate to Severe Eosinophilic Asthma
- A Randomized, Double‑Blind, Placebo‑Controlled Phase 2/3 Study of Subcutaneous PF‑07275315 in Adults with Moderate‑to‑Severe Chronic Obstructive Pulmonary Disease
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Trial of Lunsekimig in Adults with Inadequately Controlled Eosinophilic COPD
Data & Insights
Has run more than one trial at 139 of 530 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating inadequately controlled asthma, focusing on advanced inhaler therapies and bronchodilator combinations for improving lung function.
- Asthma Control Assessment
- Bronchodilator Therapy
- Inhaler-Based Treatments
The research encompasses evaluation of combination treatments using corticosteroids and long-acting bronchodilators.
COPD Treatment Innovation
The investigator explores advanced therapeutic approaches for Chronic Obstructive Pulmonary Disease, with particular attention to triple therapy combinations and cardiopulmonary outcomes.
- Triple Therapy Evaluation
- Cardiopulmonary Assessment
- Bronchodilator Combinations
Their work focuses on comparing dual and triple therapy efficacy in COPD management.
Severe Respiratory Infections
The investigator studies treatment interventions for severe viral lung infections, particularly in patients requiring supplemental oxygen support.
- Critical Care Medicine
- Oxygen Therapy Management
- Novel Therapeutic Approaches
Their research includes evaluation of targeted therapies for preventing disease progression in severe respiratory infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.